Harvard Bioscience (HBIO) EBITDA Margin Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn |
| 10 | Harvard Bioscience | 25.38 Mn | 18.29 Mn | 12.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -477.00 |
| Dec 31, 2025 | 15,824.00 |
| Sep 30, 2025 | -167.00 |
| Jun 30, 2025 | -25.00 |
| Mar 31, 2025 | -20,187.00 |
| Dec 31, 2024 | 1,009.00 |
| Sep 30, 2024 | 663.00 |
| Jun 30, 2024 | -652.00 |
| Mar 31, 2024 | -27.00 |
| Dec 31, 2023 | -1,278.00 |
| Sep 30, 2023 | -480.00 |
| Jun 30, 2023 | 1,602.00 |
| Mar 31, 2023 | 1,644.00 |
| Dec 31, 2022 | 1,427.00 |
| Sep 30, 2022 | -1,817.00 |
| Jun 30, 2022 | 519.00 |
| Mar 31, 2022 | -2,268.00 |
| Dec 31, 2021 | 939.00 |
| Sep 30, 2021 | 1,634.00 |
| Jun 30, 2021 | 990.00 |
| Mar 31, 2021 | -73.00 |
| Dec 31, 2020 | 284.00 |
| Sep 30, 2020 | 803.00 |
| Jun 30, 2020 | -1,112.00 |
| Mar 31, 2020 | -321.00 |
| Dec 31, 2019 | -171.00 |
| Sep 30, 2019 | -541.00 |
| Jun 30, 2019 | -572.00 |
| Mar 31, 2019 | -1,267.00 |
| Dec 31, 2018 | 855.00 |
| Sep 30, 2018 | -447.00 |
| Jun 30, 2018 | -1,310.00 |
| Mar 31, 2018 | -316.00 |
| Dec 31, 2017 | -584.00 |
| Sep 30, 2017 | -83.00 |
| Jun 30, 2017 | 1,181.00 |
| Mar 31, 2017 | -697.00 |
| Dec 31, 2016 | -903.00 |
| Sep 30, 2016 | -764.00 |
| Jun 30, 2016 | -1,592.00 |
| Mar 31, 2016 | -1,358.00 |
| Dec 31, 2015 | -952.00 |
| Sep 30, 2015 | -1,275.00 |
| Jun 30, 2015 | -179.00 |